Governments and health agencies should reconsider the current guidelines with regards to widespread mask use in the COVID-19 pandemic and recommend that masks be worn by everyone, argue a team of researchers at the University of Cambridge

A new test for infection with SARS-CoV2 that which inactivates the virus at the point of sampling, has been developed by a team of researchers at the Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID). It is now being used to test and screen frontline NHS staff at a Cambridge hospital.

One of Cambridge’s newest institutes, established to study the relationship between infectious disease and our immune systems, is leading the University of Cambridge’s response to the COVID-19 pandemic, with over 150 scientists and clinicians, the UK’s largest academic Containment Level 3 Facility, and a range of collaborators from across the UK and beyond. 

An online tool to illustrate the effects of different COVID-19 control measures has been developed by a team of University of Cambridge researchers.

On 22nd March 2020, Cambridge University Botanic Garden closed its gates to protect visitors and staff during the global coronavirus pandemic. Coinciding almost exactly with the start of Spring, this felt like a particularly cruel blow. 

A new rapid diagnostic test for COVID-19, developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes, is being deployed at Cambridge hospitals, ahead of being launched in hospitals nationwide.

Should we be concerned about the coronavirus spreading to cats? Not yet, says Dr Sarah Caddy in this article for The Conversation, even after a concerning report from Belgium.

The University of Cambridge is to take a leading role in a major national effort to help understand and control the new coronavirus infection (COVID-19) announced today by the Government and the UK’s Chief Scientific Adviser.

The race is on to find a vaccine against the new COVID-19 coronavirus. Professor Jonathan Heeney explains why a cautious approach is needed and how his team is using new technology developed for influenza and Ebola viruses to target the new infection.

Emma Glennon is a PhD candidate in the Department of Veterinary Medicine and a Gates Cambridge Scholar. Here, she tells us about her research on infectious disease and how they emerge, the importance of interdisciplinary work, and learning how to catch bats.